Individualized Estimates of Overdiagnosis in Screen-Detected Prostate Cancer

Assessing Non–Cancer-Related Health Status of US Cancer Patients: Other-Cause Survival and Comorbidity Prevalence

(2013) Hyunsoon Cho et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening Strategies

(2013) Roman Gulati et al.   ANNALS OF INTERNAL MEDICINE

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

(2011) R. Gulati et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Calibrating disease progression models using population data: a critical precursor to policy development in cancer control

(2010) R. Gulati et al.   BIOSTATISTICS

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute

Do we need more nomograms for predicting outcomes in patients with prostate cancer?

(2008) Michael W Kattan   Nature clinical practice. Urology